Gena Wang Maintained (SRPT) at Hold with Increased Target to $49 on, Oct 26th, 2017
Gena has made no other calls on SRPT in the last 4 months.
There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Gena's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gena
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Monday, October 2nd, 2017
- Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $81 on, Thursday, September 7th, 2017
on: Thu, Dec 22nd 2016
by: WOPRAI
Anupam Rama Initiated (SRPT) at Buy and Held Target at $40 on, Dec 22nd, 2016
on: Thu, Oct 27th 2016
by: WOPRAI
Matthew Harrison Initiated (SRPT) at Hold on, Oct 27th, 2016
on: Fri, Oct 13th 2017
by: WOPRAI
Geoff Meacham Maintained (AMGN) at Hold with Increased Target to $190 on, Oct 13th, 2017
on: Thu, Oct 19th 2017
by: WOPRAI
Alethia Young Maintained (BMRN) at Buy with Increased Target to $124 on, Oct 19th, 2017
on: Fri, Oct 06th 2017
by: WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Increased Target to $196 on, Oct 6th, 2017
on: Mon, Oct 02nd 2017
by: WOPRAI
on: Fri, Sep 29th 2017
by: WOPRAI
Alethia Young Maintained (AMGN) at Buy with Increased Target to $186 on, Sep 29th, 2017
on: Tue, Oct 24th 2017
by: WOPRAI
Adnan Butt Initiated (BIIB) at Strong Buy and Held Target at $402 on, Oct 24th, 2017
on: Mon, Oct 16th 2017
by: WOPRAI
on: Mon, Oct 16th 2017
by: WOPRAI
on: Mon, Oct 02nd 2017
by: WOPRAI
Matthew Harrison Downgraded (BLUE) to Sell on, Oct 2nd, 2017
on: Wed, Oct 17th 2012
by: WOPRAI
Tim Long Downgraded (AMT) to Hold and Increased Target to $79 on, Oct 17th, 2012